期刊文献+

卵巢上皮癌组织T淋巴细胞及树突状细胞免疫组化研究 被引量:1

A study of T lymphocytes and dendritic cells in human ovarian epithelial carcinoma
在线阅读 下载PDF
导出
摘要 目的研究卵巢上皮癌组织中T淋巴细胞、树突状细胞数量及分布,为进行卵巢癌生物治疗提供依据。方法采用ABC免疫组织化学和图像分析技术,测定人卵巢上皮癌组织和正常卵巢组织中T细胞表面分化抗原CD3、CD4、CD8,树突状细胞表型抗原CD1c、S-100阳性表达的细胞及其表达强度。结果 与正常卵巢组织相比,卵巢上皮癌中CD3+、CD8+、CD1c+、S—100+细胞数量明显减少,其表达强度明显降低,差异有显著性(P<0.05)。卵巢上皮癌中CD4+抗原阳性表达细胞数量明显减少,但其表达强度变化不明显。结论 卵巢上皮癌组织T淋巴细胞、树突状细胞数量及其表达强度发生变化,提示卵巢癌局部免疫发生改变。 Objective To investigate the number, distribution, expression intensity of T lymphocytes and dendritic cells in human ovarian epithelial carcinoma for seeking biotherapeutic evidence of ovarian carcinoma. Methods Using ABC immu-nohistochemical and computerized imaging technique, to detect the number, distribution, and expression intensity of CD3, CD4, CD8,CD1c,S- 100 positive cells in ovarian epithelial carcinoma.Results Compared with normal ovarian tissue, the number and the expression intensity of CD3+ , CD8+ , CD1c+, S - 100+ cells in ovarian carcinoma significantly. Hecreased. Although the number of CD4+ cells in ovarian epithelial carcinoma reduced significantly. However, no significant difference in its expression intensity was found. Conclusions The number and the expression intensity of T lymphocytes and dendritic cells in human ovarian epithelial carcinoma had changed. The results suggest that there are some changes in local immunologic function in human ovarian epithelial carcinoma.
出处 《中国妇产科临床杂志》 2002年第1期48-50,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
基金 国家自然科学基金资助(项目编号No.30070843)
关键词 卵巢肿瘤 免疫组织化学 淋巴细胞 树突状细胞 Ovarian Carcinoma Immunochemistry T lymphocyte Dendritic cells
  • 相关文献

参考文献8

  • 1[1]Constantin G, Ioannides CG, Chris DP, et al. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascetics. Cancer Res, 1991, 51:4257 - 4265
  • 2吕孟宇,曹德川.卵巢恶性肿瘤患者T淋巴细胞亚群的改变[J].临床医学,1996,16(1):32-33. 被引量:2
  • 3[3]Castano AR, Tangri S, Miller JEW, et al. Peptide binding and presentation by mouse CD1. Science, 1995, 269: 223 - 227
  • 4[4]Thomssen H, Ivanyi J, Espitia C, et al. Human CD4+ CD8- αβ T cell receptor T cells recognize different mycobacteria strains in the context of CD1b.Immunology, 1995, 85:33-36
  • 5[5]Eisenthal A, Polyvkin N, Bramante-Schreiber L.Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer. Hum Pathol, 2001, 32:803-807
  • 6[6]Armstrong AC, Eaton D, Ewing JC.Cellular immunotherapy for cancer. B M J, 2001, 323:1289 - 1293
  • 7[7]Lawrence F, Edgar GE. Dendritic cells in cancer immunotherapy. Annu Rev Immunol, 2000, 18: 245- 273
  • 8[8]Straten PT, Guldberg P, Seremet T, et al. Activation of preexisting T cell clones by targeted interleuekin 2 therapy. Proc Natl Acad Sci USA, 1998,95:8785-8790

共引文献1

同被引文献17

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部